• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events

SUPREME COURT WEIGHS LEGALIZATION CASE

By Alex Halperin
10/11/2020 09:29 PM GMT-0700
FacebookTweetPin

The U.S. Supreme Court is weighing whether to hear Washington vs. Barr, a case challenging marijuana’s federal illegality.
WeedWeek

  • Plaintiffs, including juvenile and veteran MED patients, and former NFL player Marvin Washington, are appealing a lower court ruling that they must exhaust their appeals to the DEA before challenging federal illegality in court. Plaintiffs argue the DEA has shown itself incapable of providing the requested relief and that federal illegality violates their Constitutional right to life-saving medicine.
  • “We’re not asking the court to change society,” the plaintiff’s lead attorney Michael Hiller said. “We’re asking the court to recognize how society has advanced, and how understanding of cannabis has advanced, and to simply take the foot off our necks, if you will, when it comes to the law.”
  • The high court only accepts about 3% of similar appeals. A decision on whether to hear the case is expected this week.

More legal news:

  • The U.S. Supreme Court declined to hear ancillary company Helix Technologies‘ appeal arguing federal employment law doesn’t apply to cannabis companies.
    WeedWeek
  • An investor asked a federal judge to impose sanctions on CBD company CV Sciences.
    WeedWeek
  • The Florida Supreme Court is hearing a challenge to mandatory vertical integration for MED license holders.
    WeedWeek
  • A court filing accuses MSO Trulieve of “doctoring” evidence in an employment-related lawsuit. The company did not respond to a request for comment.
    WeedWeek
  • Edibles maker Bhang reached a settlement in a suit accusing it of misrepresenting product potency.
    MJBiz

[gravityform id="5" title="true" description="false" ajax="true" tabindex=""]
Share:
FacebookTweetPin
Filed Under:
Federal

Primary Sidebar

Recent Webinar

Growth in a Tight Market

WeedWeek Wonks: Financial Strategy Implications of Rescheduling

Duration Broadcast March 26th
Speakers Gail Rand, Alex Halperin

WATCH NOW

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

Related Articles

See More Federal Articles
Financial
Federal

WeedWeek Wonks: Financial Strategy Implications of Rescheduling

cann
Beverages

Newsbrief: Hemp drink fight continues in D.C.

David Kay
Industry Voices

Industry Voices: Rescheduling Won’t Save Margins, Discipline Will

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2026. All Rights Reserved